Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Intangibles (2021 - 2023)

Indivior Pharmaceuticals (INDV) has 1 years of Intangibles data on record, last reported at $82.0 million in Q4 2021.

  • For Q4 2021, Intangibles changed N/A year-over-year to $82.0 million; the TTM value through Dec 2021 reached $82.0 million, changed N/A, while the annual FY2021 figure was $82.0 million, N/A changed from the prior year.
  • Intangibles reached $82.0 million in Q4 2021 per INDV's latest filing.
  • Across five years, Intangibles topped out at $82.0 million in Q4 2021 and bottomed at $82.0 million in Q4 2021.